Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
International breast cancer prevention study launches in U.S., Canada
April 19th, 2005
A new clinical trial evaluating a novel approach to breast cancer prevention has launched in the United States and Canada. Called the ExCel research study, this is the first North American clinical trial to evaluate the role of an aromatase inhibitor in the prevention of breast cancer. Coordinated by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), the ExCel research study will examine the potential benefit of exemestane and its ability to prevent breast cancer in women who are at increased risk for the disease. Exemestane - part of a class of drugs called aromatase inhibitors - suppresses estrogen...
Source: Cancer Weekly (2005-04-19)
|
